JP2005075826A - 多孔質シリカ担体を含有する徐放性製剤 - Google Patents

多孔質シリカ担体を含有する徐放性製剤 Download PDF

Info

Publication number
JP2005075826A
JP2005075826A JP2003346310A JP2003346310A JP2005075826A JP 2005075826 A JP2005075826 A JP 2005075826A JP 2003346310 A JP2003346310 A JP 2003346310A JP 2003346310 A JP2003346310 A JP 2003346310A JP 2005075826 A JP2005075826 A JP 2005075826A
Authority
JP
Japan
Prior art keywords
porous silica
controlled release
core
active compound
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003346310A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005075826A5 (enrdf_load_stackoverflow
Inventor
Masatoshi Chikasawa
正敏 近澤
Takashi Takei
孝 武井
Masatada Fuji
正督 藤
Kenzo Toyoshima
健三 豊島
Kotoe Ota
琴恵 太田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Tama TLO Co Ltd
Original Assignee
Boehringer Ingelheim International GmbH
Tama TLO Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH, Tama TLO Co Ltd filed Critical Boehringer Ingelheim International GmbH
Priority to JP2003346310A priority Critical patent/JP2005075826A/ja
Publication of JP2005075826A publication Critical patent/JP2005075826A/ja
Publication of JP2005075826A5 publication Critical patent/JP2005075826A5/ja
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
JP2003346310A 2003-08-29 2003-08-29 多孔質シリカ担体を含有する徐放性製剤 Pending JP2005075826A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003346310A JP2005075826A (ja) 2003-08-29 2003-08-29 多孔質シリカ担体を含有する徐放性製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003346310A JP2005075826A (ja) 2003-08-29 2003-08-29 多孔質シリカ担体を含有する徐放性製剤

Publications (2)

Publication Number Publication Date
JP2005075826A true JP2005075826A (ja) 2005-03-24
JP2005075826A5 JP2005075826A5 (enrdf_load_stackoverflow) 2006-10-12

Family

ID=34419511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003346310A Pending JP2005075826A (ja) 2003-08-29 2003-08-29 多孔質シリカ担体を含有する徐放性製剤

Country Status (1)

Country Link
JP (1) JP2005075826A (enrdf_load_stackoverflow)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008081539A1 (ja) * 2006-12-28 2008-07-10 National University Corporation Akita University 多孔質シリカを用いた乳酸菌等有用菌含有サプリメント
JP2009274972A (ja) * 2008-05-13 2009-11-26 Maruzen Pharmaceut Co Ltd アレルゲン不活性化剤及びアレルゲン不活性化材
JP2011037852A (ja) * 2009-08-08 2011-02-24 Evonik Degussa Gmbh 口腔衛生に使用するための複合体粒子
JP2011519714A (ja) * 2008-02-13 2011-07-14 エボニック デグサ ゲーエムベーハー プレミックス配合物の貯蔵安定性製品システム
JP2013194036A (ja) * 2012-03-22 2013-09-30 Kobayashi Pharmaceutical Co Ltd 医薬組成物
CN105377243A (zh) * 2013-08-08 2016-03-02 生物技术株式会社 利用水难溶性物质的稳定三层胶囊及其制备方法以及利用其的化妆品组合物
US9891239B2 (en) 2007-02-23 2018-02-13 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
US10039718B2 (en) 2008-05-02 2018-08-07 Gilead Sciences, Inc. Use of solid carrier particles to improve the processability of a pharmaceutical agent
WO2021182469A1 (ja) * 2020-03-11 2021-09-16 沢井製薬株式会社 顆粒及びそれを用いた製剤
JP2021175733A (ja) * 2020-04-22 2021-11-04 沢井製薬株式会社 コーティング粒子及びそれを含む口腔内崩壊錠
JP7738697B2 (ja) 2020-03-11 2025-09-12 沢井製薬株式会社 顆粒及びそれを用いた製剤

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6281479A (ja) * 1985-10-04 1987-04-14 Sumitomo Electric Ind Ltd 粉末状含液組成物の製造方法
JPH01106817A (ja) * 1987-10-21 1989-04-24 Kiteii:Kk 多孔質内封入体及びその製造方法
JPH072648A (ja) * 1993-04-23 1995-01-06 Ciba Geigy Ag 徐放性ドラッグデリバリーデバイス
WO2003026626A2 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Modified release dosage forms

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6281479A (ja) * 1985-10-04 1987-04-14 Sumitomo Electric Ind Ltd 粉末状含液組成物の製造方法
JPH01106817A (ja) * 1987-10-21 1989-04-24 Kiteii:Kk 多孔質内封入体及びその製造方法
JPH072648A (ja) * 1993-04-23 1995-01-06 Ciba Geigy Ag 徐放性ドラッグデリバリーデバイス
WO2003026626A2 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Modified release dosage forms

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008081539A1 (ja) * 2006-12-28 2008-07-10 National University Corporation Akita University 多孔質シリカを用いた乳酸菌等有用菌含有サプリメント
JPWO2008081539A1 (ja) * 2006-12-28 2010-04-30 国立大学法人秋田大学 多孔質シリカを用いた乳酸菌等有用菌含有サプリメント
US9891239B2 (en) 2007-02-23 2018-02-13 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
JP2011519714A (ja) * 2008-02-13 2011-07-14 エボニック デグサ ゲーエムベーハー プレミックス配合物の貯蔵安定性製品システム
US10039718B2 (en) 2008-05-02 2018-08-07 Gilead Sciences, Inc. Use of solid carrier particles to improve the processability of a pharmaceutical agent
JP2009274972A (ja) * 2008-05-13 2009-11-26 Maruzen Pharmaceut Co Ltd アレルゲン不活性化剤及びアレルゲン不活性化材
JP2011037852A (ja) * 2009-08-08 2011-02-24 Evonik Degussa Gmbh 口腔衛生に使用するための複合体粒子
JP2013194036A (ja) * 2012-03-22 2013-09-30 Kobayashi Pharmaceutical Co Ltd 医薬組成物
EP3031453A4 (en) * 2013-08-08 2017-05-31 Biogenics, Inc. Stable triple-layer capsule using poorly water-soluble substance, manufacturing method therefor and cosmetic composition using same
JP2016523896A (ja) * 2013-08-08 2016-08-12 バイオジェニックス インコーポレイテッド 水難溶性物質を用いた安定化した三重層カプセル、その製造方法及びこれを用いた化粧品組成物
CN105377243A (zh) * 2013-08-08 2016-03-02 生物技术株式会社 利用水难溶性物质的稳定三层胶囊及其制备方法以及利用其的化妆品组合物
WO2021182469A1 (ja) * 2020-03-11 2021-09-16 沢井製薬株式会社 顆粒及びそれを用いた製剤
JPWO2021182469A1 (enrdf_load_stackoverflow) * 2020-03-11 2021-09-16
JP7467596B2 (ja) 2020-03-11 2024-04-15 沢井製薬株式会社 顆粒及びそれを用いた製剤
JP2024081778A (ja) * 2020-03-11 2024-06-18 沢井製薬株式会社 顆粒及びそれを用いた製剤
JP7738697B2 (ja) 2020-03-11 2025-09-12 沢井製薬株式会社 顆粒及びそれを用いた製剤
JP2021175733A (ja) * 2020-04-22 2021-11-04 沢井製薬株式会社 コーティング粒子及びそれを含む口腔内崩壊錠
JP2021175732A (ja) * 2020-04-22 2021-11-04 沢井製薬株式会社 コハク酸ソリフェナシン含有コーティング粒子及びそれを含む口腔内崩壊錠
JP7672268B2 (ja) 2020-04-22 2025-05-07 沢井製薬株式会社 コハク酸ソリフェナシン含有コーティング粒子及びそれを含む口腔内崩壊錠

Similar Documents

Publication Publication Date Title
US5670171A (en) Liquid-suspension controlled-release pharmaceutical composition
EP1194131B1 (en) Pharmaceutical dosage forms for controlled release producing at least a timed pulse
ES2568746T3 (es) Sistemas de liberación pulsátil controlada
JP5636364B2 (ja) 徐放性骨格筋弛緩薬剤形の調製
BG65306B1 (bg) Лекарствена форма с контролирано освобождаване, съдържаща галантамин
EP0601508B1 (en) Liquid-suspension controlled-release pharmaceutical composition
JP2005075826A (ja) 多孔質シリカ担体を含有する徐放性製剤
WO2001010467A1 (fr) Preparations solides contenant de la poudre de chitosane et procede de production associe
CN1956707B (zh) 包含n-(2-(2-苯二酰亚氨基乙氧基)-乙酰基)-l-丙氨酰基-d-谷氨酸(lk-423)的耐胃酸的药物剂型
US20060073205A1 (en) Controlled release granules comprising porous silica core
PL192950B1 (pl) Wielocząstkowa postać farmaceutyczna o opóźnionym i stopniowym uwalnianiu, oraz sposób jej wytwarzania
EP1839649A1 (en) Coated formulations for tolterodine
GB2098867A (en) Sustained release pharmaceutical composition
WO2018219897A1 (en) Multiparticulate oral dosage form providing prolonged release of tapentadol
CA2438438A1 (en) Controlled release granules comprising porous silica core
CZ118899A3 (cs) Kompozice s pozvolným uvolňováním léčiva, způsob přípravy této kompozice, způsob zlepšení profilu uvolňování léčiva a použití této kompozice
WO2010036975A2 (en) Dipyridamole and acetylsalicylic acid formulations and process for preparing same
MXPA03007749A (es) Granulos de liberacion controlada que comprenden un nucleo de silice porosa.
EP3612196A2 (en) Polymer based formulation for release of drugs and bioactives at specific git sites
CN101530387B (zh) 口服迟释药物制剂
KR100858631B1 (ko) 인다파미드가 함유된 서방형 펠렛
WO2010078878A1 (en) Duloxetine formulations

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060825

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060825

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100218

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100805